Recipient of federal assistance

LIBERO PHARMA LIMITED

LIBERO PHARMA LIMITED received $0 in federal grants and other assistance in FY2026, on 1 actions. It has no federal contracts in the loaded years. Since FY2022: $6.4M.

Assistance · FY2026
$0
New awards
0
Actions
1
Since FY2022
$6.4M
UEI
KDK7WQD2CZQ7
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 3.2MFY2022
  2. 3.2MFY2023
  3. 0FY2024
  4. 0FY2025
  5. 0FY2026

Top programs · Awarding agencies

Obligations in FY2026.

Largest awards

  1. NALTREXONE TRANSDERMAL PATCH - AN ACCESSIBLE, PATIENT-FOCUSED OPTION TO TREAT OUD RELAPSE - THE U.S. REMAINS FIRMLY IN THE GRIP OF A…$6.4M
    93.279 · Drug Use and Addiction Research Programs· National Institutes of Health· Cooperative agreement· Sep 21, 2022 – Jul 14, 2026· UG3DA057853

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2022–FY2026.